<?xml version="1.0" encoding="UTF-8"?>
<p>Helicase (Nsp13) is a multifunctional protein (predicted to have 596 aa in SARS-CoV-2) essential for SARS-CoVs RNA replication and proliferation.
 <xref rid="B74" ref-type="bibr">
  <sup>74</sup>
 </xref>
 <sup>,</sup>
 <xref rid="B99" ref-type="bibr">
  <sup>99</sup>
 </xref> SARS-CoV helicase belongs to helicase superfamily 1 (SF1) and can unwind double-stranded DNAs/RNAs (helicase activity) in the 5’-3’ direction, an energy-consuming process that is driven by the hydrolysis of nucleosides triphosphate (NTPase activity).
 <xref rid="B57" ref-type="bibr">
  <sup>57</sup>
 </xref>
 <sup>,</sup>
 <xref rid="B100" ref-type="bibr">
  <sup>100</sup>
 </xref>
 <sup>,</sup>
 <xref rid="B101" ref-type="bibr">
  <sup>101</sup>
 </xref> Its structure contains five domains arranged in a triangular pyramid-shape: the triangular base is composed by two “RecA-like” (1A and 2A) and 1B domains whereas the zinc binding domain (ZBD), in the N-terminal, and the stalk domain are oriented towards the apex. The ZBD and 1B domains are connected by the stalk domain (
 <xref ref-type="fig" rid="f7">Fig. 7</xref>).
 <xref rid="B101" ref-type="bibr">
  <sup>101</sup>
 </xref> The same domain arrangement is predicted to occur in SARS-CoV-2 enzyme.
 <xref rid="B74" ref-type="bibr">
  <sup>74</sup>
 </xref> SARS-CoV helicase has been explored as a potential target for drugs.
 <xref rid="B99" ref-type="bibr">
  <sup>99</sup>
 </xref>
 <sup>,</sup>
 <xref rid="B100" ref-type="bibr">
  <sup>100</sup>
 </xref>
 <sup>,</sup>
 <xref rid="B102" ref-type="bibr">
  <sup>102</sup>
 </xref> Recently, some efforts have also been made to predict inhibitors for SARS-CoV-2 helicase.
 <xref rid="B74" ref-type="bibr">
  <sup>74</sup>
 </xref>
 <sup>,</sup>
 <xref rid="B103" ref-type="bibr">
  <sup>103</sup>
 </xref>
 <sup>,</sup>
 <xref rid="B104" ref-type="bibr">
  <sup>104</sup>
 </xref>
 <sup>,</sup>
 <xref rid="B105" ref-type="bibr">
  <sup>105</sup>
 </xref> They include drugs used in the clinics to treat acquired immunodeficiency syndrome (AIDS), such as vapreotide (11) (somatostatin analog) and atazanavir (12) (HIV protease inhibitor), as well anti-HCV protease inhibitors [e.g., daclatasvir (13)] and bismuth salts [e.g., bismuth potassium citrate (14), a compound used in clinical treatment of gastrointestinal diseases].
 <xref rid="B103" ref-type="bibr">
  <sup>103</sup>
 </xref>
 <sup>,</sup>
 <xref rid="B104" ref-type="bibr">
  <sup>104</sup>
 </xref>
 <sup>,</sup>
 <xref rid="B106" ref-type="bibr">
  <sup>106</sup>
 </xref>
</p>
